Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Amrita Krishnan, MD, City of Hope, Duarte, CA, outlines what was discussed at the ‘treatment of newly diagnosed myeloma transplant eligible’ plenary session she chaired at the International Myeloma Workshop (IMW) 2019, held in Boston, MA. The CASSIOPEIA study (NCT02541383) was the key point of discussion.
We use cookies to provide the best experience on our website. We also use third party cookies to collect analytical data and better improve our marketing strategies. If you continue to use this site you are consenting to the use of these cookies. For more information view our Cookie Policy.